StonvexLoading…
StonvexStonvexStonvexCore line items from CELH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $912.20M | $782.62M | $2.52B | $1.79B | $1.07B |
Operating Income | Not available | $138.99M | $141.06M | $115.00M | $195.00M |
Net Income | Not available | $110.10M | $108.00M | $83.26M | $99.86M |
EPS (Diluted) | $0.45 | $0.33 | $0.25 | $0.22 | $0.48 |
Total Assets | Not available | $5.16B | $5.12B | $5.27B | $3.80B |
Total Liabilities | Not available | $2.15B | $2.18B | $2.30B | $1.70B |
Cash & Equivalents | Not available | $549.20M | $398.87M | $805.96M | $615.23M |
Free Cash Flow OCF − CapEx | Not available | $65.81M | $323.38M | $453.34M | $131.88M |
Shares Outstanding | Not available | 256.55M | 256.91M | 257.78M | 257.77M |